Oncotelic Therapeutics, Inc. Amortization of Debt Issuance Costs
Oncotelic Therapeutics, Inc. (OTLC) reported Amortization of Debt Issuance Costs of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-13
- Oncotelic Therapeutics, Inc. amortization of debt issuance costs for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Oncotelic Therapeutics, Inc. amortization of debt issuance costs for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Oncotelic Therapeutics, Inc. amortization of debt issuance costs for the quarter ending 2025-12-31 was $11.00K.
- Oncotelic Therapeutics, Inc. amortization of debt issuance costs for the quarter ending 2025-09-30 was $19.90K.
- Oncotelic Therapeutics, Inc. amortization of debt issuance costs for fiscal 2025 was $112.00K, a 28.66% decline from fiscal 2024.
- Oncotelic Therapeutics, Inc. amortization of debt issuance costs for fiscal 2024 was $157.00K.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $11.00K derived: sum of 3 quarters · filed 2026-08-13 | $30.90K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | $11.00K derived: sum of 2 quarters · filed 2026-05-14 | $30.90K derived: sum of 3 quarters · filed 2026-05-14 | $69.90K derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $30.90K derived: sum of 2 quarters · filed 2026-04-15 | $69.90K derived: sum of 3 quarters · filed 2026-04-15 | $112.00K 10-K · filed 2026-04-15 |
| 2025-09-30 | $19.90K 10-Q · filed 2025-11-17 | $58.90K derived: sum of 2 quarters · filed 2025-11-17 | $101.00K 10-Q · filed 2025-11-17 | |
| 2025-06-30 | $39.00K 10-Q · filed 2025-08-13 | $78.00K 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | $38.00K 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | $157.00K 10-K · filed 2026-04-15 |